Michelle Renee Griffin, Director at Adaptive Biotechnologies Corp (ADPT), sold 12,000 shares at $57.42 ($706K) on 2020-12-14, disclosed to the SEC on 2020-12-16.
Open-market sale of $706k ADPT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $57.42 | 982 | $56K | 8.0% |
| 2 | $57.42 | 982 | $56K | 8.0% |
| 3 | $58.96 | 3,367 | $199K | 28.1% |
| 4 | $58.96 | 3,367 | $199K | 28.1% |
| 5 | $59.44 | 1,651 | $98K | 13.9% |
| 6 | $59.44 | 1,651 |
| $98K |
| 13.9% |
| Total | $58.84 avg | 12,000 | $706K | 100% |
| Filing → |
| ADPT | SELL | 2026-03-05 | $735K | — | Filing → |
| ADPT | SELL | 2025-03-17 | $522K | — | Filing → |
| ADPT | SELL | 2025-03-06 | $249K | — | Filing → |